"It's becoming kind of a cornerstone of treatment for people with gastrointestinal problems diabetes, and obviously more recently, weight loss, with astounding effect sizes," Levinthal said
A 2020 study comparing weekly semaglutide to daily subcutaneous liraglutide showed a more significant overall weight loss in those that received semaglutide
[10] Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial | Cardiovascular Diabetology | Springer Nature Link
As eating habits change on GLP-1 medications, magnesium intake may decrease, especially if you are consuming fewer whole foods
Where do I find the COA for my batch
These medications are also meant to be taken long-term, typically for a year or longer